Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Current Assets (2020 - 2025)

Sotera Health (SHC) has 6 years of Current Assets data on record, last reported at $577.8 million in Q3 2025.

  • For Q3 2025, Current Assets rose 2.52% year-over-year to $577.8 million; the TTM value through Sep 2025 reached $577.8 million, up 2.52%, while the annual FY2024 figure was $526.0 million, 5.6% down from the prior year.
  • Current Assets reached $577.8 million in Q3 2025 per SHC's latest filing, up from $555.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $645.0 million in Q4 2022 and bottomed at $328.4 million in Q1 2021.
  • Average Current Assets over 5 years is $485.8 million, with a median of $526.0 million recorded in 2024.
  • Peak YoY movement for Current Assets: skyrocketed 86.44% in 2022, then dropped 13.61% in 2023.
  • A 5-year view of Current Assets shows it stood at $346.0 million in 2021, then surged by 86.44% to $645.0 million in 2022, then decreased by 13.61% to $557.2 million in 2023, then dropped by 5.6% to $526.0 million in 2024, then rose by 9.84% to $577.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $577.8 million in Q3 2025, $555.0 million in Q1 2025, and $526.0 million in Q4 2024.